ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.

Jordan L Kohlmeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.